Premium
Dendritic cells fused with core binding factor‐beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes
Author(s) -
Banat G.Andre,
Usluoglu Nurguel,
Hoeck Marianne,
Ihlow Kerstin,
Hoppmann Sabine,
Pralle Hans
Publication year - 2004
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2004.05087.x
Subject(s) - cytotoxic t cell , cd8 , immunology , major histocompatibility complex , biology , antigen presenting cell , t cell , antigen , cd40 , cancer research , immune system , in vitro , biochemistry
Summary Several reports have described various strategies of dendritic cell (DC) vaccination to induce specific T‐cell responses in patients with acute myeloid leukaemia (AML). About 50–60% of AML cases blasts have chromosomal abnormalities, such as inv(16) or t(8,21), which could encode for leukaemia‐specific antigenic peptide sequences, possibly presented in the context of self‐major histocompatibility complex (MHC) molecules. As the co‐culture of AML blasts with T lymphocytes seldom resulted in T‐cell stimulation, we fused AML blasts with autologous DC to enhance this effect. The fusion cells expressed MHC class I and II, CD40, B7‐1, B7‐2, CD209 and several adhesion molecules. In a mixed lymphocyte hybrid reaction, the fusion cells induced the proliferation of autologous T cells. Moreover, in the special case of fusion cells established from AML blasts with the chromosomal abnormality inv(16), the autologous T lymphocytes could be primed to induce cytotoxicity against up to 70% autologous AML blasts in a effector:target ratio of 20:1. Blocking assays demonstrated that the lysis was chiefly mediated by CD8 + , CCR7 − T lymphocytes, which could be further expanded in the form of effector memory CD8 + T cells by repeated co‐cultures with the autologous fusion cells.